搜索筛选:
搜索耗时0.0806秒,为你在为你在102,285,761篇论文里面共找到 6 篇相符的论文内容
类      型:
[会议论文] 作者:Han Wei,Guoliang Liu,Chenglin Sun,Xinhai Xu,Yebin Che,Peng Jing,Feng Gao,Peicheng Zhang,Ning Ru,Guaghui Cui, 来源:中国免疫学会第九届全国免疫学学术大会 年份:2014
[会议论文] 作者:Baofa Yu,Yuanfei Lu,Peng Jing,Han Wei,Feng Gao,Peicheng Zhang,Guoliang Liu,Ning Ru,Guaghui Cui,Chenglin, 来源:中国免疫学会第九届全国免疫学学术大会 年份:2014
Background: Lung cancer remains the leading cause of cancer-related deaths.As a first-line treatment with chemotherapy, several agents clinically approved in targeted therapies for lung cancer exhibit...
[会议论文] 作者:Han Wei,Guoliang Liu,Chenglin Sun,Xinhai Xu,Yebin Che,Peng Jing,Feng Gao,Peicheng Zhang,Ning Ru,Guaghui Cui, 来源:中国免疫学会第九届全国免疫学学术大会 年份:2014
[会议论文] 作者:Han Wei,Guoliang Liu,Chenglin Sun,Xinhai Xu,Yebin Che,Peng Jing,Feng Gao,Peicheng Zhang,Ning Ru,Guaghui Cui, 来源:中国免疫学会第九届全国免疫学学术大会 年份:2014
[会议论文] 作者:Baofa Yu,Yuanfei Lu,Qiang Fu,Peng Jing,Han Wei,Feng Gao,Peicheng Zhang,Guoliang Liu,Ning Ru,Guaghui Cui, 来源:中国免疫学会第九届全国免疫学学术大会 年份:2014
Background: Ultra-minimum incision personalized intratumoral chemoimmunotherapy (UMIPIC) is a new option for cancer treatment integrating local chemotherapeutic effect with systematic antitumor immuni...
[会议论文] 作者:Baofa Yu,Yuanfei Lu,Qiang Fu,Peng Jing,Han Wei,Feng Gao,Peicheng Zhang,Guoliang Liu,Ning Ru,Guaghui Cui, 来源:中国免疫学会第九届全国免疫学学术大会 年份:2014
Background: Pancreatic cancer remains one of the most malignant and aggressive cancers.We have applied intratumoral therapy with the combined drugs in the treatment of advanced pancreatic cancer patie...
相关搜索: